Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP in Androgenetic Alopecia
NCT02074943Unknown
- Sponsor
- Vancouver General Hospital
- Start
- Apr 2014
- Primary completion
- Jun 2015
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised, double-blind trial of platelet-rich plasma in androgenetic alopecia (AGA), sponsored by Vancouver General Hospital. Primary endpoint: Hair Regrowth Score at 16 weeks. Status: unknown.
02
Drugs
platelet-rich plasma
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT02074943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02074943.